Abstract
To determine differences in the ability of Mycobacterium tuberculosis strains to withstand antituberculosis drug treatment, we compared the activity of antituberculosis drugs against susceptible Beijing and East-African/Indian genotype M. tuberculosis strains. Beijing genotype strains showed high rates of mutation within a wide range of drug concentrations, possibly explaining this genotype's association with multidrug-resistant tuberculosis.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amikacin / pharmacology
-
Antitubercular Agents / pharmacology*
-
Aza Compounds / pharmacology
-
Bacterial Proteins / genetics
-
Drug Resistance, Multiple, Bacterial / genetics*
-
Fluoroquinolones
-
Genotype
-
Isoniazid / pharmacology
-
Microbial Sensitivity Tests
-
Moxifloxacin
-
Mutation
-
Mycobacterium tuberculosis / drug effects*
-
Mycobacterium tuberculosis / genetics
-
Quinolines / pharmacology
-
Rifampin / pharmacology
-
Statistics, Nonparametric
-
Tuberculosis, Multidrug-Resistant / microbiology*
Substances
-
Antitubercular Agents
-
Aza Compounds
-
Bacterial Proteins
-
Fluoroquinolones
-
Quinolines
-
Amikacin
-
Moxifloxacin
-
Isoniazid
-
Rifampin